27449508|t|Modulation of Interleukins in Sepsis - Associated Clotting Disorders: Interplay With Hemostatic Derangement
27449508|a|Interleukins play a central role in the immune system and are involved in a variety of immunological, inflammatory, and infectious disease states including sepsis syndrome. Levels of interleukins may correlate with overall survival and may directly or indirectly affect some of the regulators of coagulation and fibrinolysis, thereby disrupting hemostasis and thrombosis. Our hypothesis is that in sepsis-associated coagulopathies (SACs), interleukins may be upregulated, leading to hemostatic imbalance by generating thrombogenic mediators. We profiled the levels of interleukins IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, and IL-10 in addition to d-dimer (DD) in patients with SAC and in normal donors. We observed the highest increase in interleukins IL-6 (322-fold), IL-8 (48-fold), IL-10 (72-fold), and DD (18-fold). This suggests that interleukins such as IL-6 and IL-10 have a close association with coagulopathy and fibrinolytic dysregulation in sepsis and can be considered as candidates for potential therapeutic targets in SAC.
27449508	0	10	Modulation	T082	UMLS:C0443264
27449508	14	26	Interleukins	T103	UMLS:C0021764
27449508	30	36	Sepsis	T038	UMLS:C0036690
27449508	50	68	Clotting Disorders	T038	UMLS:C0005779
27449508	85	107	Hemostatic Derangement	T038	UMLS:C0005779
27449508	108	120	Interleukins	T103	UMLS:C0021764
27449508	128	135	central	T082	UMLS:C0205099
27449508	148	161	immune system	T022	UMLS:C0020962
27449508	195	208	immunological	T038	UMLS:C0021053
27449508	210	222	inflammatory	T038	UMLS:C1290884
27449508	228	246	infectious disease	T038	UMLS:C0009450
27449508	264	279	sepsis syndrome	T038	UMLS:C0036690
27449508	291	303	interleukins	T103	UMLS:C0021764
27449508	371	377	affect	T038	UMLS:C0001721
27449508	390	400	regulators	T103	UMLS:C0005525
27449508	404	415	coagulation	T038	UMLS:C0005778
27449508	420	432	fibrinolysis	T038	UMLS:C0016017
27449508	453	463	hemostasis	T038	UMLS:C0019116
27449508	468	478	thrombosis	T038	UMLS:C0040053
27449508	506	538	sepsis-associated coagulopathies	T038	UMLS:C0005779
27449508	540	544	SACs	T038	UMLS:C0005779
27449508	547	559	interleukins	T103	UMLS:C0021764
27449508	567	578	upregulated	T038	UMLS:C0041904
27449508	591	611	hemostatic imbalance	T038	UMLS:C0005779
27449508	626	648	thrombogenic mediators	T103	UMLS:C0574031
27449508	676	688	interleukins	T103	UMLS:C0021764
27449508	689	694	IL-1α	T103	UMLS:C0600251
27449508	696	701	IL-1β	T103	UMLS:C0021753
27449508	703	707	IL-2	T103	UMLS:C0021756
27449508	709	713	IL-4	T103	UMLS:C0021758
27449508	715	719	IL-6	T103	UMLS:C0021760
27449508	721	725	IL-8	T103	UMLS:C0079633
27449508	731	736	IL-10	T103	UMLS:C0085295
27449508	752	759	d-dimer	T103	UMLS:C0060323
27449508	761	763	DD	T103	UMLS:C0060323
27449508	782	785	SAC	T038	UMLS:C0005779
27449508	800	806	donors	T098	UMLS:C0005795
27449508	844	856	interleukins	T103	UMLS:C0021764
27449508	857	861	IL-6	T103	UMLS:C0021760
27449508	874	878	IL-8	T103	UMLS:C0079633
27449508	890	895	IL-10	T103	UMLS:C0085295
27449508	911	913	DD	T103	UMLS:C0060323
27449508	944	956	interleukins	T103	UMLS:C0021764
27449508	965	969	IL-6	T103	UMLS:C0021760
27449508	974	979	IL-10	T103	UMLS:C0085295
27449508	1010	1022	coagulopathy	T038	UMLS:C0005779
27449508	1057	1063	sepsis	T038	UMLS:C0036690
27449508	1089	1099	candidates	T103	UMLS:C0021764
27449508	1137	1140	SAC	T038	UMLS:C0005779